Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | SBI-755199 |
Synonyms | |
Therapy Description |
SBI-755199, a structural analog of the eIF4F complex inhibitor SBI-0640756, inhibits mRNA initiation and induces cell death in human cancer cell lines (PMID: 26603897). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
SBI-755199 | SBI-755199, a structural analog of the eIF4F complex inhibitor SBI-0640756, inhibits mRNA initiation and induces cell death in human cancer cell lines (PMID: 26603897). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
BRAF V600E | melanoma | sensitive | SBI-755199 | Preclinical | Actionable | In a preclinical study, SBI-755199 induced cell death in human melanoma cell lines harboring BRAF V600E in culture (PMID: 26603897). | 26603897 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|